Status:
UNKNOWN
Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborating Sponsors:
Shanghai Zhongshan Hospital
RenJi Hospital
Conditions:
Gastric Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The researching subject is aimed to obtain the clinical evidences (including real benefits， risks ,etc. ) of traditional Chinese medicine in the treatment of advanced gastric cancer by compared with t...
Detailed Description
The purpose of this project is to further evaluate the role of traditional Chinese medicine in the treatment of advanced gastric cancer through clinical registration along with real world study. The ...
Eligibility Criteria
Inclusion
- gastric adenocarcinoma without operation or recurrence after operation or metastasis
- diagnosed within three months
- KPS score≥60
- expected survival time was above 3 months
- HB ≥80g/L 、WBC≥4.0×109/L、 N ≥2.0×109/L 、PLA ≥80×109/L
- normal function with heart 、kidney and liver
Exclusion
- not gastric adenocarcinoma
- simultaneous diagnosis with other malignant tumor
- participate in clinical trials of new drugs not listed in China
- combined with myocardial infarction, cerebral infarction, severe liver and kidney dysfunction, postoperative severe complications
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT02781285
Start Date
December 1 2014
End Date
December 1 2022
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Longhua Hospital
Shanghai, Shanghai Municipality, China, 20032